IMS and QuantiaMD have teamed up to promote a system where doctors can "prescribe" apps and the system can track downloads (though not usage). IMS has been curating apps for a couple of years and is now expanding the system's reach with the partnership with QuantiaMD.
“Doctors are getting progressively more comfortable prescribing apps,” Matt Tindall, general manager of IMS Health’s consumer solutions business, told mHealth News. “But they need help picking specific treatment and therapies for their patients.”
Apps are still fairly new for the HCP market. It is still possible for healthcare marketers to make a material difference in their patients’ lives by providing useful apps for condition and therapy monitoring.
Is the glass 15% full and rising? Or is the glass still 85% empty?
A poll of 415 doctors in the US found:
- 15% are talking to patients about mHealth apps
- 42% think non-users could benefit from using apps
- 40% think non-users could benefit from using wearables
How you see these stats depends on what you think will happen in the next five years. We’re definitely in the 15% and rising camp.